Failure of regeneration of the steatotic rat liver: disruption at two different levels in the regeneration pathway.
Hepatic resection or transplantation in patients with fatty liver is associated with increased morbidity and mortality. The regenerative capacity of fatty livers after major tissue loss is unknown. Interleukin 6 (IL-6) is a potent inducer of hepatic regeneration in normal and ischemic livers. Therefore, we studied hepatic regeneration at day 1, day 2, and day 4 in a model of 70% hepatectomy in obese and lean Zucker rats, and obese Zucker rats pretreated with recombinant interleukin 6 (rIL-6). The mitotic cycle in hepatocytes was investigated by 4 different markers of regeneration representing distinct phases of mitosis (proliferating cell nuclear antigen [PCNA] = G(1) phase, bromodeoxy uridine [BrdU] = S phase, mitotic index, and regenerated liver weight = M phase). Obese Zucker rats had significantly decreased regenerative capacity compared with lean Zucker rats (PCNA, BrdU, mitotic index, regenerated liver weight) at days 1 and 2 after surgery. Four days after resection fatty animals showed an increase in the mitotic index indicating a delay of regeneration in steatotic livers. Animal survival after 70% hepatectomy was significantly decreased in obese rats compared with lean animals. Pretreatment of obese animals with rIL-6 normalized PCNA expression (G(1) phase) in steatotic hepatocytes but failed to increase DNA synthesis (BrdU, S phase), mitosis (mitotic index and regenerated liver weight, M phase), and animal survival. These results indicate major impairment of hepatic regeneration in steatotic livers. Two different blockages of regeneration must be present, one rIL-6 sensitive, at the level of IL-6 or upstream, and a second, rIL-6 resistant, at the level of G(1)/S-phase transition.
Selzner
M
M
Laboratory of Liver Transplantation and Hepatobiliary Surgery, Department of Surgery, Duke University Medical Center, Durham, NC, USA.
Clavien
P A
PA
D000818:Animals; D017209:Apoptosis; D002453:Cell Cycle; D005234:Fatty Liver / Q000473:pathology / Q000503:physiopathology / Q000601:surgery*; D016193:G1 Phase; D006498:Hepatectomy; D007274:Injections, Intraperitoneal; D015850:Interleukin-6 / Q000494:pharmacology; D008115:Liver Regeneration; D009336:Necrosis; D009765:Obesity / Q000150:complications; D018809:Proliferating Cell Nuclear Antigen / Q000032:analysis; D051381:Rats; D011924:Rats, Zucker; D011994:Recombinant Proteins / Q000494:pharmacology; D016196:S Phase
D015850:Interleukin-6; D018809:Proliferating Cell Nuclear Antigen; D011994:Recombinant Proteins